Skip to content

TAXUS PHARMACEUTICALS HOLDINGS, INC.

CIK 0001622676

← back to feed
Revenue (TTM)
$23.61K
−90.4% YoY Q3 Mar 2018
Net Income (TTM)
−$30.41K
+56.2% YoY Q3 Mar 2018
EPS Diluted (TTM)
—
Q3 Mar 2018
Gross Margin
33.2%
Q3 Mar 2018
Operating Margin
—
Q3 Mar 2018
Net Margin
-128.8%
Q3 Mar 2018
Free Cash Flow (TTM)
—
Q3 Mar 2018
Cash
$5.84K
Q3 Mar 2018
Total Debt
—
Q3 Mar 2018
Shares Outstanding
81.5M sh
Q3 Mar 2018

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings